| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Calcium Chloride | Calcium Chloride 10% In Plastic Container | 4.3 Contraindications | Ceftriaxone use | May,2023 |
| Ketorolac | Ketothrom | 4.4 Special Warnings and Special Precautions for Use | Increased risk of gastro-intestinal anastomotic leak | May,2023 |
| Ropinirole | Requip | 4.8 Undesirable effects | Spontaneous penile erection and Hiccups | Apr,2023 |
| Ustekinumab | Stelara | 4.4 Special Warnings and Special Precautions for Use | Inclusion of cardiovascular risk based on PSOLAR study observations | Apr,2023 |
| Carbetocin | Pabal Rts | 4.8 Undesirable effects | Bradycardia, hypersensitivity | Apr,2023 |
| Darunavir | Prezista | 4.8 Undesirable effects | Crystal nephropathy, crystalluria, redistribution of fat | Apr,2023 |